Glaucoma

Latest News


CME Content


Compliance is a common concern with glaucoma patients, but a study recently published in Ophthalmology found that generic medication may help increase adherence, possibly due to lower cost.

Reuters recently reported on a new wave of drugs in development that it says will shake up glaucoma treatments. When the consumer media is giving your patients direct information about eye care, are you ready to answer their questions?

Glaucoma is a term that describes a family of progressive optic neuropathies. All of the glaucomas share characteristic and progressive cupping of the optic nerve head, and this cupping is most easily viewed by means of direct stereoscopic evaluation through a dilated pupil.

Reasons for thin CCT values as independent predictors of POAG have been relatively unclear, and there aren’t nearly as many studies concerning CCT as there are concerning risk factors such as IOP.

Neovascular glaucoma is a potentially devastating ocular consequence of pathologic neovascularization of intraocular tissue. The symptoms include vision loss caused by both the underlying etiology (such as retinal vascular disease) as well as increased intraocular pressure (IOP), often accompanied by corneal edema, hyphema, or vitreous hemorrhage.

Seems like everyone is focusing on baby boomers as they enter a new phase of their lives, but vision in particular is a big topic. And why wouldn’t it be? What is more critical to healthy aging than maintaining healthy vision?

Over the last decade, there has been rapid growth in the management of glaucoma. Innovative imaging technologies that aid in the diagnosis of this vision-threatening disease have also been on the rise. Instead of relying on a single diagnostic tool, clinicians may consider leveraging the benefits of several modalities available today.

According to the National Eye Institute (NEI), 7.7 million people age 40 and older have diabetic retinopathy, and this number is projected to increase to approximately 11 million people by 2030.

Your patients may have seen wife of rapper T.I. and reality star Tameka “Tiny” Harris appear on Good Morning America this week to reveal she had undergone surgery to permanently change her brown eyes to “ice gray,” sparking a national conversation about the safety of such a procedure.

A recent study published in the Journal of Glaucoma found that there was no detected increase in glaucoma risk with current, recent, or past use of systemic fluoroquinolones, but did find a minimal statistically significant increased risk with distant use.

Despite some perceptions, generic pharmaceutical drugs are not necessarily less effective than their branded counterparts. But their true claim to fame is in cheaper pricing, undercutting the brand-name alternatives sometimes by orders of magnitude. But according to Dr. Milton Hom, OD, FAAO, price shouldn't take on the main consideration.

A 24-year-old was referred to the Ocular Disease Service at UAB Eye Care for a glaucoma evaluation. Other than a history of spectacle correction for myopic refractive error, the personal ophthalmic history is negative.

I recently came across a journal publication describing a patient with Crohn’s disease and open-angle glaucoma.1 Essentially, the patient’s treatment with topical latanoprost was associated with an exacerbation of her Crohn’s disease.

The American Academy of Ophthalmology (AAOphth) has reiterated its stance on medical marijuana for the treatment of glaucoma, stating that it finds no scientific evidence that marijuana is an effective long-term treatment for the disease, particularly when compared to the current prescription medication and surgical treatment available.